Insights on Pharmaceutical Diagnostics and Future Growth in Healthcare

This chapter covers insights from a recent investor day that emphasized the rapid growth of the pharmaceutical diagnostic segment, particularly in imaging agents and radio pharmaceuticals for targeted cancer therapy. It also provides an analysis of the Chinese healthcare market, forecasting a slower recovery in early 2025 but a positive growth outlook for the second half of the year.